+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

3D Bioprinting Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • PDF Icon

    Report

  • 95 Pages
  • November 2024
  • Region: Global
  • Prof Research
  • ID: 5726599

Quick Summary:

In the rapidly evolving world of healthcare technologies, 3D Bioprinting has emerged as a crucial and transformative sector, fueling groundbreaking innovations across a multitude of industries. Investing in our comprehensive market research report will provide you with an in-depth understanding of this dynamic market, highlighting key trends, identifying market leaders, and revealing opportunities for growth and advancement.

Our report encompasses a meticulous evaluation of the global 3D Bioprinting market, offering a granular overview of key geographic markets, including North America, South America, Europe, Asia & Pacific, and MEA. It also benchmarks leading international players, offering a thorough SWOT analysis and crucial details such as business information, revenue, gross margin, and market share. Moreover, it provides a comprehensive segmentation of 3D bioprinting into hardware, software, and service. The insights derived from this report will equip you to better navigate the competitive landscape of 3D Bioprinting and align your business strategies for optimum outcomes.

The 3D bioprinting market is an innovative segment within the larger bioprinting industry, characterized by its capacity to use biological cells and biomaterials to fabricate tissue structures. This technology combines principles from both 3D printing and biotechnology to create elaborate constructs that can be utilized in tissue engineering, regenerative medicine, pharmaceutical research, and more. The global 3D bioprinting market has witnessed significant growth over the last few years and is anticipated to continue this upward trajectory between 2024 and 2029.

Market Size and Growth Projections

As of 2023, the global 3D bioprinting market was valued at approximately USD 1.2 billion. With increasing investments in bioprinting technologies and rising applications in medical fields, the market is projected to expand at a CAGR of around 13% from 2024 to 2029. Consequently, it is expected to reach about USD 2.5 billion by the end of 2029.

Market Share & Trends Analysis Report

By Product Type

The 3D bioprinting market can be segmented into various product types, including:
  • Bio-printers: This segment accounted for the largest share, driven by technological advancements and increased adoption in clinical practices.
  • Bio-inks: With a rising focus on the customization of bio-inks, this segment is expected to rise rapidly, estimating a CAGR of 15% over the forecast period.
  • Other Products: This includes software and consumables, which are also witnessing consistent growth.

By Key Players

The competitive landscape features key players that shape the dynamics of the market. Major companies include:
  • Organovo Holdings, Inc.
  • 3D Systems Corporation
  • Aspect Biosystems Ltd.
  • Stratasys Ltd.
  • EnvisionTEC, Inc.
  • These companies are focusing on R&D activities, partnerships, and mergers to capitalize on market opportunities.

By Process

The market can be classified into different processes used in bioprinting:
  • Extrusion-Based Bioprinting: This is the most commonly utilized method, responsible for a substantial market share with a forecasted growth in applications.
  • Laser-Assisted Bioprinting: Expected to grow at a significant rate due to its precision in fabricating complex structures.
  • Other Processes: Are also relevant but lag behind the above categories in terms of market share.

By Application

The primary applications of 3D bioprinting include:
  • Drug Testing & Development: Companies increasingly use 3D bioprinting for developing drug testing platforms to evaluate medications efficiently.
  • Tissue Engineering: The demand for tissue constructs for transplantation needs is driving growth within this application.
  • Others: This encompasses applications in regenerative medicine and cosmetics.

By End-Use

The end-use sector primarily consists of the following:
  • Biotechnology Companies: This sector leads market adoption, focusing on engineering regenerative tissues and organ models.
  • Research Institutions: Academic research institutions are significant users, leveraging 3D bioprinting for varied studies.
  • Pharmaceutical Companies: Increasingly integrating bioprinting technologies for drug development processes.

By Region

The geographical analysis of the market includes:
  • North America: Held the largest market share (approximately 37%) in 2023, fueled by technological advancements and strong investment by key players.
  • Europe: Following closely, with a forecasted CAGR of 12% due to a strong academic and research network.
  • Asia-Pacific: Expected to witness the highest growth rate, driven by increasing healthcare expenditures and technological adoption.

Market News on Policy and Companies

In recent years, various governmental and regulatory bodies have started to focus on standardizing bioprinting technologies which is essential for gaining market traction and public acceptance. Policies encouraging bioprinting research and development, especially in areas such as organ transplantation, have reinforced funding initiatives.

Notably, companies like Organovo have announced breakthroughs in creating complex liver tissues that mimic natural organs, underlining the potential of bioprinting in regenerative medicine. Additionally, 3D Systems has heightened its focus on plastic and biocompatible material innovations, ensuring its competitive positioning within the landscape.

Segment Forecasts 2024 - 2029

Despite the promising growth of the 3D bioprinting market, there are some challenges to consider. Regulatory hurdles and technical complexities of material properties may limit certain applications, particularly in clinical scenarios.
However, ongoing advancements in bioprinting technologies, such as the development of sophisticated bio-inks and better printer resolutions, coupled with increasing collaboration between tech firms and healthcare providers, are set to propel growth further. By 2029, the market is projected to adapt significantly, promoting both innovation in applications and broader accessibility to 3D bioprinting technologies.

Conclusion

In conclusion, the 3D bioprinting market is witnessing robust growth due to innovations and rising applications across various fields, especially in tissue engineering and pharmaceutical development. With increasing investments, an expanding player base, and supportive regulatory environments, the market is poised for accumulation of both technological advancements and commercial opportunities through 2029.


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 3D Bioprinting Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast 3D Bioprinting Market in North America (2019-2029)
8.1 3D Bioprinting Market Size
8.2 3D Bioprinting Market by End Use
8.3 Competition by Players/Suppliers
8.4 3D Bioprinting Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast 3D Bioprinting Market in South America (2019-2029)
9.1 3D Bioprinting Market Size
9.2 3D Bioprinting Market by End Use
9.3 Competition by Players/Suppliers
9.4 3D Bioprinting Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast 3D Bioprinting Market in Asia & Pacific (2019-2029)
10.1 3D Bioprinting Market Size
10.2 3D Bioprinting Market by End Use
10.3 Competition by Players/Suppliers
10.4 3D Bioprinting Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast 3D Bioprinting Market in Europe (2019-2029)
11.1 3D Bioprinting Market Size
11.2 3D Bioprinting Market by End Use
11.3 Competition by Players/Suppliers
11.4 3D Bioprinting Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast 3D Bioprinting Market in MEA (2019-2029)
12.1 3D Bioprinting Market Size
12.2 3D Bioprinting Market by End Use
12.3 Competition by Players/Suppliers
12.4 3D Bioprinting Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global 3D Bioprinting Market (2019-2024)
13.1 3D Bioprinting Market Size
13.2 3D Bioprinting Market by End Use
13.3 Competition by Players/Suppliers
13.4 3D Bioprinting Market Size by Type
Chapter 14 Global 3D Bioprinting Market Forecast (2024-2029)
14.1 3D Bioprinting Market Size Forecast
14.2 3D Bioprinting Application Forecast
14.3 Competition by Players/Suppliers
14.4 3D Bioprinting Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Advanced Solutions Life Sciences
15.1.1 Company Profile
15.1.2 Main Business and 3D Bioprinting Information
15.1.3 SWOT Analysis of Advanced Solutions Life Sciences
15.1.4 Advanced Solutions Life Sciences 3D Bioprinting Revenue, Gross Margin and Market Share (2019-2024)
15.2 Aspect Biosystems
15.2.1 Company Profile
15.2.2 Main Business and 3D Bioprinting Information
15.2.3 SWOT Analysis of Aspect Biosystems
15.2.4 Aspect Biosystems 3D Bioprinting Revenue, Gross Margin and Market Share (2019-2024)
15.3 Bio3D Technologies
15.3.1 Company Profile
15.3.2 Main Business and 3D Bioprinting Information
15.3.3 SWOT Analysis of Bio3D Technologies
15.3.4 Bio3D Technologies 3D Bioprinting Revenue, Gross Margin and Market Share (2019-2024)
15.4 3D Systems/Allevi
15.4.1 Company Profile
15.4.2 Main Business and 3D Bioprinting Information
15.4.3 SWOT Analysis of 3D Systems/Allevi
15.4.4 3D Systems/Allevi 3D Bioprinting Revenue, Gross Margin and Market Share (2019-2024)
15.5 Cyfuse Biomedical K.K.
15.5.1 Company Profile
15.5.2 Main Business and 3D Bioprinting Information
15.5.3 SWOT Analysis of Cyfuse Biomedical K.K.
15.5.4 Cyfuse Biomedical K.K. 3D Bioprinting Revenue, Gross Margin and Market Share (2019-2024)
15.6 Organovo
15.6.1 Company Profile
15.6.2 Main Business and 3D Bioprinting Information
15.6.3 SWOT Analysis of Organovo
15.6.4 Organovo 3D Bioprinting Revenue, Gross Margin and Market Share (2019-2024)
15.7 Rokit
15.7.1 Company Profile
15.7.2 Main Business and 3D Bioprinting Information
15.7.3 SWOT Analysis of Rokit
15.7.4 Rokit 3D Bioprinting Revenue, Gross Margin and Market Share (2019-2024)
15.8 Novoheart
15.8.1 Company Profile
15.8.2 Main Business and 3D Bioprinting Information
15.8.3 SWOT Analysis of Novoheart
15.8.4 Novoheart 3D Bioprinting Revenue, Gross Margin and Market Share (2019-2024)
15.9 3D Bioprinting Solutions
15.9.1 Company Profile
15.9.2 Main Business and 3D Bioprinting Information
15.9.3 SWOT Analysis of 3D Bioprinting Solutions
15.9.4 3D Bioprinting Solutions 3D Bioprinting Revenue, Gross Margin and Market Share (2019-2024)
15.10 Wake Forest Institute for Regenerative Medicine
15.10.1 Company Profile
15.10.2 Main Business and 3D Bioprinting Information
15.10.3 SWOT Analysis of Wake Forest Institute for Regenerative Medicine
15.10.4 Wake Forest Institute for Regenerative Medicine 3D Bioprinting Revenue, Gross Margin and Market Share (2019-2024)
15.11 BioLife4D Corp
15.11.1 Company Profile
15.11.2 Main Business and 3D Bioprinting Information
15.11.3 SWOT Analysis of BioLife4D Corp
15.11.4 BioLife4D Corp 3D Bioprinting Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of 3D Bioprinting Report
Table Data Sources of 3D Bioprinting Report
Table Major Assumptions of 3D Bioprinting Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure 3D Bioprinting Picture
Table 3D Bioprinting Classification
Table 3D Bioprinting Applications
Table Drivers of 3D Bioprinting Market
Table Restraints of 3D Bioprinting Market
Table Opportunities of 3D Bioprinting Market
Table Threats of 3D Bioprinting Market
Table COVID-19 Impact For 3D Bioprinting Market
Table Raw Materials Suppliers
Table Different Production Methods of 3D Bioprinting
Table Cost Structure Analysis of 3D Bioprinting
Table Key End Users
Table Latest News of 3D Bioprinting Market
Table Merger and Acquisition
Table Planned/Future Project of 3D Bioprinting Market
Table Policy of 3D Bioprinting Market
Table 2019-2029 North America 3D Bioprinting Market Size
Figure 2019-2029 North America 3D Bioprinting Market Size and CAGR
Table 2019-2029 North America 3D Bioprinting Market Size by Application
Table 2019-2024 North America 3D Bioprinting Key Players Revenue
Table 2019-2024 North America 3D Bioprinting Key Players Market Share
Table 2019-2029 North America 3D Bioprinting Market Size by Type
Table 2019-2029 United States 3D Bioprinting Market Size
Table 2019-2029 Canada 3D Bioprinting Market Size
Table 2019-2029 Mexico 3D Bioprinting Market Size
Table 2019-2029 South America 3D Bioprinting Market Size
Figure 2019-2029 South America 3D Bioprinting Market Size and CAGR
Table 2019-2029 South America 3D Bioprinting Market Size by Application
Table 2019-2024 South America 3D Bioprinting Key Players Revenue
Table 2019-2024 South America 3D Bioprinting Key Players Market Share
Table 2019-2029 South America 3D Bioprinting Market Size by Type
Table 2019-2029 Brazil 3D Bioprinting Market Size
Table 2019-2029 Argentina 3D Bioprinting Market Size
Table 2019-2029 Chile 3D Bioprinting Market Size
Table 2019-2029 Peru 3D Bioprinting Market Size
Table 2019-2029 Asia & Pacific 3D Bioprinting Market Size
Figure 2019-2029 Asia & Pacific 3D Bioprinting Market Size and CAGR
Table 2019-2029 Asia & Pacific 3D Bioprinting Market Size by Application
Table 2019-2024 Asia & Pacific 3D Bioprinting Key Players Revenue
Table 2019-2024 Asia & Pacific 3D Bioprinting Key Players Market Share
Table 2019-2029 Asia & Pacific 3D Bioprinting Market Size by Type
Table 2019-2029 China 3D Bioprinting Market Size
Table 2019-2029 India 3D Bioprinting Market Size
Table 2019-2029 Japan 3D Bioprinting Market Size
Table 2019-2029 South Korea 3D Bioprinting Market Size
Table 2019-2029 Southeast Asia 3D Bioprinting Market Size
Table 2019-2029 Australia 3D Bioprinting Market Size
Table 2019-2029 Europe 3D Bioprinting Market Size
Figure 2019-2029 Europe 3D Bioprinting Market Size and CAGR
Table 2019-2029 Europe 3D Bioprinting Market Size by Application
Table 2019-2024 Europe 3D Bioprinting Key Players Revenue
Table 2019-2024 Europe 3D Bioprinting Key Players Market Share
Table 2019-2029 Europe 3D Bioprinting Market Size by Type
Table 2019-2029 Germany 3D Bioprinting Market Size
Table 2019-2029 France 3D Bioprinting Market Size
Table 2019-2029 United Kingdom 3D Bioprinting Market Size
Table 2019-2029 Italy 3D Bioprinting Market Size
Table 2019-2029 Spain 3D Bioprinting Market Size
Table 2019-2029 Belgium 3D Bioprinting Market Size
Table 2019-2029 Netherlands 3D Bioprinting Market Size
Table 2019-2029 Austria 3D Bioprinting Market Size
Table 2019-2029 Poland 3D Bioprinting Market Size
Table 2019-2029 Russia 3D Bioprinting Market Size
Table 2019-2029 MEA 3D Bioprinting Market Size
Figure 2019-2029 MEA 3D Bioprinting Market Size and CAGR
Table 2019-2029 MEA 3D Bioprinting Market Size by Application
Table 2019-2024 MEA 3D Bioprinting Key Players Revenue
Table 2019-2024 MEA 3D Bioprinting Key Players Market Share
Table 2019-2029 MEA 3D Bioprinting Market Size by Type
Table 2019-2029 Egypt 3D Bioprinting Market Size
Table 2019-2029 Israel 3D Bioprinting Market Size
Table 2019-2029 South Africa 3D Bioprinting Market Size
Table 2019-2029 Gulf Cooperation Council Countries 3D Bioprinting Market Size
Table 2019-2029 Turkey 3D Bioprinting Market Size
Table 2019-2024 Global 3D Bioprinting Market Size by Region
Table 2019-2024 Global 3D Bioprinting Market Size Share by Region
Table 2019-2024 Global 3D Bioprinting Market Size by Application
Table 2019-2024 Global 3D Bioprinting Market Share by Application
Table 2019-2024 Global 3D Bioprinting Key Vendors Revenue
Figure 2019-2024 Global 3D Bioprinting Market Size and Growth Rate
Table 2019-2024 Global 3D Bioprinting Key Vendors Market Share
Table 2019-2024 Global 3D Bioprinting Market Size by Type
Table 2019-2024 Global 3D Bioprinting Market Share by Type
Table 2024-2029 Global 3D Bioprinting Market Size by Region
Table 2024-2029 Global 3D Bioprinting Market Size Share by Region
Table 2024-2029 Global 3D Bioprinting Market Size by Application
Table 2024-2029 Global 3D Bioprinting Market Share by Application
Table 2024-2029 Global 3D Bioprinting Key Vendors Revenue
Figure 2024-2029 Global 3D Bioprinting Market Size and Growth Rate
Table 2024-2029 Global 3D Bioprinting Key Vendors Market Share
Table 2024-2029 Global 3D Bioprinting Market Size by Type
Table 2024-2029 3D Bioprinting Global Market Share by Type

Companies Mentioned

  • Advanced Solutions Life Sciences
  • Aspect Biosystems
  • Bio3D Technologies
  • 3D Systems/Allevi
  • Cyfuse Biomedical K.K.
  • Organovo
  • Rokit
  • Novoheart
  • 3D Bioprinting Solutions
  • Wake Forest Institute for Regenerative Medicine
  • BioLife4D Corp

Methodology

Loading
LOADING...